Inovio Pharmaceuticals (INO) Q3 2024 Earnings Call Transcript
Inovio Pharmaceuticals ( INO -3.64%) Q3 2024 Earnings Call Nov 14, 2024, 4:30 p.m. ET
Inovio Pharma Stock Slips Ahead of Q3 Earnings: Retail’s Bullish
Shares of Inovio Pharmaceuticals ($INO) slipped nearly 2% on Thursday afternoon ahead of the company’s third-quarter results, with retail sentiment staying bullish. Wall Street analysts expect earnings per share (EPS) of around -$1.
Inovio Pharmaceuticals Inc. Q3 Loss Narrows
Inovio Pharmaceuticals Inc. (INO) reported Loss for third quarter that decreased from last year The company's earnings totaled
A Preview Of Inovio Pharmaceuticals's Earnings
Inovio Pharmaceuticals INO is preparing to release its quarterly earnings on Thursday, 2024-11-14. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect Inovio Pharmaceuticals to report an earnings per share (EPS) of $-1.
Inovio: Q3 Earnings Snapshot
On a per-share basis, the Plymouth Meeting, Pennsylvania-based company said it had a loss of 89 cents. The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.20 per share.
Vuzix (VUZI) Q3 2024 Earnings Call Transcript
VUZI earnings call for the period ending September 30, 2024. Vuzix ( VUZI -0.92%) Q3 2024 Earnings Call Nov 14, 2024, 4:30 p.m. ET Greetings and welcome to the Vuzix third quarter for the period ending September 30th,
Sow Good Inc. (SOWG) Q3 2024 Earnings Call Transcript
Q3 2024 Earnings Conference Call November 14, 2024 10:00 AM ET. Company Participants. Cody Slach - Investor Relations Claudia Goldfarb - Co-Founder and
Sonos (SONO) Q4 2024 Earnings Call Transcript
Thank you for standing by, and welcome to the Sonos fourth quarter 2024 conference call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session.
Business Insider1d
Inovio reports data from Phase 1/2 trial on INO-3107
INOVIO (INO) announced new immunology data that supports the clinical activity of its lead product candidate, INO-3107, that was previously observed in a Phase 1/2 trial of RRP patients. In that ...
gematsu3d
2.5D pixel art narrative adventure game Rusty Winter announced for PC
Publisher Astrolabe Games and solo developer Ino Kinwen have announced Rusty Winter, a 2.5D pixel art narrative-focused ...
CNN10mon
Inovio Pharmaceuticals, Inc.
Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting ...
Yahoo Finance24d
INOVIO Announces New Data at Scientific Conferences for Lead Candidate, INO-3107, as a Potential Treatment for RRP
American Association for Cancer Research (AACR) Special Conference: Tumor Immunology and Immunotherapy: New immunology data showed ability of INO-3107 to induce an antigen-specific T cell response ...
INO-3107显示出减少RRP患者手术需求的前景
宾夕法尼亚州普利茅斯会议 - 专注于DNA疗法的生物技术公司INOVIO (NASDAQ:INO)发布了新的免疫学数据，表明其主要产品候选药物INO-3107可能会减少复发性呼吸道乳头状瘤病(RRP)患者的手术需求。这种疾病通常由人乳头状瘤病毒6型和11型(HPV-6和HPV-11)引起，会导致气道中良性肿瘤的生长，可能阻碍呼吸并对语言产生不利影响。 这些将在第36届国际乳头状瘤病毒会议上展示的数 ...
Morningstar22d
Inovio Pharmaceuticals Inc INO
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
RumbleOn, Inc. Reports Q3 2024 Earnings
Rumbleon, Inc. ( (RMBL) ) has released its Q3 earnings. Here is a breakdown of the information Rumbleon, Inc. presented to its investors.